CRISPR Technology: Implications for the Insurance Industry and Beyond

February 28, 2020

Dr. Steven J. Rigatti, consulting medical director to CRL, discusses the novel use of the CRISPR technique and its potential… Read More

Tags: CRISPR, Crispr Cas9, Dna, Life Insurance, Sickle Cell